癌症治疗对宫癌患者的不良影响
Mahesh Palagudi1, Sneha Para2, Nagasree Golla3
1Department of General Medicine, P.E.S. Institute of Medical Sciences and Research, Kuppam, IND.
Cureus
|March 15, 2024
概括
癌症治疗,特别是组合疗法,在印度的宫癌患者中引起不良反应 (AE). 胃肠道问题最常见,特别是在36-50岁的年龄组.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 临床医学 临床医学
背景情况:
- 关于包括印度在内的低收入至中等收入国家的宫癌患者癌症治疗不良影响 (AE) 的数据有限.
- 解决这一知识差距对于改善患者生活质量至关重要.
研究的目的:
- 评估各种癌症治疗组合在宫癌患者的不良影响 (AE).
主要方法:
- 在印度对1,030名患有宫癌的妇女进行了观察性,回顾性研究.
- 2019年10月至2022年11月期间从医疗记录中收集的数据.
- 描述性的横截面设计分析了多学科咨询期间报告的AEs.
主要成果:
- 大多数患者 (56.0%) 经历了辐射疗法和化疗联合的副作用.
- 胃肠道的不良反应最为普遍,影响了92.5%的患者.
- 年龄在36-50岁之间的患者报告了最多的AE发生率 (30.2%).
结论:
- 癌症治疗,特别是组合疗法,导致宫癌患者的显著不良影响.
- 这些副作用发生在治疗期间和治疗后,突出显示需要全面的管理策略.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
200
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
200
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
162
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
162
Disorders of the Female Reproductive System
357
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
357
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
288
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
288


